Obermatt
See Similar Stocks →

Embla Medical

CPH:EMBLA · IS0000000040
Health Care Equipment & SuppliesMedium

360

61
EV / EBIT37
Price / Owner Earnings38
Owner Earnings Yield70
Dividend Yield1
Price/Sales63
EV / Gross Profit51
Price/Book60
Return on Capital63
Cash Return on Capital67
Return on Equity75
EBIT Margin71
Gross Profitability46
Cash Conversion39
Accruals38
Owner Earnings Margin74
Sales growth47
Profit Growth73
Long-Term EPS Growth80
Owner Earnings Growth66
Reinvestment24
Price momentum27
Debt load46
Refinancing70
Debt Payback24
Liquidity77
Analyst ratings22
Opinion Changes50
Price Target Upside49
Market mood57
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Embla Medical clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIceland
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeCPSE
Founded1971
Employees313
Websiteemblamedical.com
ISINIS0000000040
Last UpdateApr 2, 2026
Index & Theme
Assistive TechnologyBiomedical EngineeringOrthopaedicsManufacturingMedicalMedical Device

Description

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products. The company primarily focuses on enhancing the mobility and quality of life for individuals with physical impairments. Founded on the principle of 'Non-inv…

Analysis

Middle-of-the-road

Embla Medical hf. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 19.3× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 6% yearly growth; analysts expect 16%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is stretched. The company scores 10/20 on our value-creation score: creating some value.

What to watch: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
49
2023202420252026

All-time high

75

Mar 2026

All-time low

35

Jan 2025

Average rank

49

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
63
49
56
55
Price/Earnings
23
42
44
35
Price/Book
60
54
58
50
Dividend Yield
1
1
1
1
Value (overall)
30
30
43
45

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Embla Medical with its peers
Ottobock SE & Co
GER:OBCK
54
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Pharming
AEX:PHARM
77
CountryNetherlands
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Capital Limited
LSE:CAPD
100
CountryUK
IndustryMetals & Mining
SizeSmall
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
InMode
NSQ:INMD
86
CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
OKYO Pharma
NAQ:OKYO
40
CountryUK
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →